These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9673808

  • 41. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
    Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM.
    Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study.
    van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ.
    Neurology; 2003 Feb 25; 60(4):630-3. PubMed ID: 12601104
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Mixing sumatriptan: a prospective study of stratified care using multiple formulations.
    Kaniecki RG.
    Headache; 2001 Oct 25; 41(9):862-6. PubMed ID: 11703472
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
    Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M.
    Obstet Gynecol; 2003 Oct 25; 102(4):835-42. PubMed ID: 14551015
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial.
    Dowson AJ, Charlesworth BR, Green J, Färkkilä M, Diener HC, Hansen SB, Gawel M, INDEX Study Group.
    Headache; 2005 Jan 25; 45(1):17-24. PubMed ID: 15663608
    [Abstract] [Full Text] [Related]

  • 56. Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain.
    Pascual J, Fité B, López-Gil A.
    Headache; 2002 Feb 25; 42(2):93-8. PubMed ID: 12005301
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P, Ricalde O, Le Force B, Saper J, Margul B.
    Arch Neurol; 1996 Feb 25; 53(2):180-4. PubMed ID: 8639069
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.